Pulse: Industry Perspectives

Movember: Bringing men’s health to the forefront

Monday, November 21, 2016

The Pulse on Global Trials by Matthew Howes

Globally, men’s health outcomes are significantly worse than women’s—a paradox, given that more men participate in clinical trials than women. Across the world, men die an average of six years younger than women.

[Read More]

Go directly to the source—Patients

Monday, November 14, 2016

The Pulse on Patient Recruitment by Ashley Tointon

With more companies working on patient-centric initiatives, it’s a good time to appraise what is being done to enhance the patient’s clinical trial experience. Although there is no agreed-upon definition of the term patient centricity, the premise is to put patients first.

[Read More]

Always assure proper training in clinical researchers

Monday, November 7, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The introduction to clinical research is thrilling for new investigators and staff. The opportunity to participate in drug discovery and contribute to the development of innovative disease treatment beguiles like a magical elixir—it can obscure the enormity of the commitment required. There is far more involved in starting a clinical research practice or new research position than a patient database, medical license and the ability to obtain vital signs and draw blood. It is a challenging assimilation of establishing infrastructure, negotiating contracts and regulatory approvals and solidifying sponsor relationships to solicit the trials necessary to support cost.

[Read More]

How to develop efficiency in the study start-up process

Monday, October 31, 2016

The Pulse on Site Success by Christophe Berthoux

There are a number of perspectives related to the clinical research study start-up phase and how sites can best manage issues during this critical time frame. A number of elements are involved to efficiently achieve study start-up; however, these moving parts increase the likelihood of an opportunity for delay. Many experienced research sites aim to shorten timelines by taking advantage of the lag time that occurs between receipt of the contract and awaiting finalization for actual start-up. Streamlining the study start-up phase will not only facilitate smooth management from an internal standpoint, but it also may strengthen the relationship the site has with the sponsor or CRO, thus positioning the site well for the potential to gain more opportunities in the future.

[Read More]

Crowdsourcing, citizen science and the future of clinical trials

Monday, October 24, 2016

The Pulse on Global Trials by Matthew Howes

The recent unveiling of OpenTrials.net marks an important milestone in the democratization of data. Bringing together multiple sources of clinical research information, from ClinicalTrials.gov, PubMed, EU CTR, WHO ICTRP and many others, this advanced search engine promises to bring the bourgeoning area of citizen science further into the mainstream.

[Read More]

Healthcare as a service offering

Monday, October 17, 2016

The Pulse on Patient Recruitment by Ashley Tointon

Healthcare is one of the most personal services you can encounter. As a patient, consider how the healthcare experience compares to other personal service offerings. In other service offerings, the importance of the overall experience, the personal touch and the perceived value of the service is what determines repeat business. As a patient in a clinical research study these same factors determine whether you will participate and may also determine whether you remain in the study or terminate your participation.

[Read More]

Perception is everything, even in clinical research

Tuesday, October 11, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The adage “perception is everything” is especially applicable to clinical research. How an organization is perceived, whether based on individual employee performance or collective employee achievement, will help drive business development. It will influence business retention and serves as the starting ground on which to build a solid reputation. If crafted with care and followed with integrity, the right perception transforms to impression, and ultimately, partnership.

[Read More]

Building the site/sponsor/CRO relationship through the feasibility process

Monday, October 3, 2016

The Pulse on Site Success by Christophe Berthoux

Clinical research studies are becoming increasingly complex with studies that may have challenging inclusion/exclusion criteria, urgent timelines or competing studies. These are only a few factors that increase the potential for delays and which have significant implications regarding time and cost. Delays can severely impact an organization. The most effective means of mitigating the risk for delays is conducting a comprehensive clinical trial feasibility assessment.

[Read More]

The long road of multiple sclerosis research

Monday, September 26, 2016

The Pulse on Global Trials by Matthew Howes

Multiple sclerosis (MS), a chronic, autoimmune, inflammatory neurological disease of the central nervous system, is the largest neuro disease affecting young people. In MS, the immune system attacks the protective sheath, called myelin, that covers nerve fibers. Communication between the brain and the body becomes disrupted and nerves become damaged.

[Read More]

Tactics for recruiting diverse patient populations

Monday, September 19, 2016

The Pulse on Patient Recruitment by Ashley Tointon

Patient Recruitment strategies are not the same for all patient populations. The recruitment strategies that work well in a phase III psoriasis study will not be the same as those that work well for a phase II pediatric type 2 diabetes trial. Recruitment strategies will differ among different genders, ethnicities, incomes and ages. In order to develop a sound strategy, you first must understand your audience and then dive deeper to understand preferred mediums and uncover credibility factors that should be considered in the messaging and the medium of recruitment activities.

[Read More]